Stay updated on AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:18:18.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner was added announcing NIH website transition updates and saying that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.8%
    Check dated 2026-10-25T14:21:05.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T14:27:35.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T15:19:33.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new revision v3.7.0 was added to the study history. An older revision v3.6.6 was removed, updating the visible version history for the study record.
    Difference
    0.1%
    Check dated 2026-09-20T19:25:29.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The study record history adds a new revision entry (v3.6.6) and removes the previous one (v3.6.5), signaling an update to the record.
    Difference
    0.1%
    Check dated 2026-08-30T22:00:28.000Z thumbnail image

Stay in the know with updates to AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.